Literature DB >> 26261622

Effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model.

Xiaolong Li1, Yan Lu1, Yi Sun1, Qi Zhang1.   

Abstract

OBJECTIVE: Our objective is to explore the effect of curcumin on permeability of coronary artery and expression of related proteins in rat coronary atherosclerosis heart disease model.
METHODS: 45 healthy male Wistar rats of clean grade were selected and divided into treatment group, model control group and blank control group. The rats in the treatment group and model control group received high-fat diet for 12 weeks and intraperitoneal injection of VD3 to establish rat coronary atherosclerosis heart disease model. After modeling, the rats in the treatment group received gavage of 100 mg/(kg·d) curcimin, and the rats in the model control group and blank control group received gavage of 5 ml/(kg·d) distilled water, the intervention time was 4 weeks. After intervention, the rats were killed, and the hearts were dissected to obtain the samples of coronary artery. After embedding and frozen section, immunofluorescence method was used to detect the change of endarterium permeability in 3 groups, Western blot was used to detect matrix metalloproteinase-9 (MMP-9) and CD40L in coronary artery tissue, and enzyme linked immunosorbent assay (ELISA) was used to detect serum tumor necrosis factor-α (TNF-α) and C reaction protein (CRP).
RESULTS: After modeling, compared with the blank control group, total cholesterol (TC), triglyceride (TG) and low density lipoprotein cholesterin (LDL-c) in the treatment group and model control group were significantly higher (P<0.05), however, high density lipoprotein cholesterin (HDL-c) was significantly lower. The pathological sections showed that there was lipidosis in rat coronary artery in treatment group and model control group, indicating that the modeling was successful. Immunofluorescence showed that there was only a little fluorochrome permeability in artery in blank control group, there was some fluorochrome permeability in artery in the treatment group and there was a lot of fluorochrome permeability in artery in the model control group. MMP-9 and CD40L in coronary artery tissue in the model control group were significantly higher than the treatment group (P<0.05), MMP-9 and CD40L in coronary artery tissue in the treatment group were significantly higher than the blank control group (P<0.05); serum TNF-α and CRP in the model control group were significantly higher than the treatment group (P<0.05), which were significantly higher in the treatment group than the blank control group (P<0.05).
CONCLUSION: Rat coronary atherosclerosis heart disease model can be successfully established by feeding with high-fat diet and intraperitoneal injection of VD3, the permeability of coronary artery in coronary heart disease rat model is significantly increased, which may be related to up-regulation of MMP-9, CD40L, TNF-α and CRP expression. Application of curcumin can inhibit expression of MMP-9, CD40L, TNF-α and CRP to improve the permeability of coronary artery.

Entities:  

Keywords:  CD40L; CRP; Curcumin; MMP-9; TNF-α; coronary artery; coronary atherosclerosis heart disease; permeability

Mesh:

Substances:

Year:  2015        PMID: 26261622      PMCID: PMC4525956     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  32 in total

1.  Total and differential white blood cell counts predict eight-year incident coronary heart disease in elderly Japanese-American men: the Honolulu Heart Program.

Authors:  Shigehiko Karino; Bradley J Willcox; Kaon Fong; Serena Lo; Robert Abbott; Kamal H Masaki
Journal:  Atherosclerosis       Date:  2014-12-09       Impact factor: 5.162

2.  Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.

Authors:  Dharam J Kumbhani; Gregg C Fonarow; Christopher P Cannon; Adrian F Hernandez; Eric D Peterson; W Frank Peacock; Warren K Laskey; Prakash Deedwania; Maria Grau-Sepulveda; Lee H Schwamm; Deepak L Bhatt
Journal:  Am J Med       Date:  2014-11-26       Impact factor: 4.965

3.  Do different metabolic syndrome definitions predict cerebrovascular events and coronary heart disease independent of their components?: 9 years follow-up of the tehran lipid and glucose study.

Authors:  Farzad Hadaegh; Reza Mohebi; Leila Cheraghi; Maryam Tohidi; Nahid Beladi Moghaddam; Mohammadreza Bozorogmanesh; Farhad Sheikholeslami; Fereidoun Azizi
Journal:  Stroke       Date:  2012-03-01       Impact factor: 7.914

4.  Development and evaluation of curcumin-loaded elastic vesicles as an effective topical anti-inflammatory formulation.

Authors:  Rumjhum Agrawal; Simarjot Kaur Sandhu; Ikksheta Sharma; Indu Pal Kaur
Journal:  AAPS PharmSciTech       Date:  2014-10-16       Impact factor: 3.246

5.  Anti-inflammatory potential of curcumin and quercetin in rats: role of oxidative stress, heme oxygenase-1 and TNF-α.

Authors:  Gehan H Heeba; Magda E Mahmoud; Amr A El Hanafy
Journal:  Toxicol Ind Health       Date:  2012-09-28       Impact factor: 2.273

6.  Comparison of vascular response between durable and biodegradable polymer-based drug-eluting stents in a porcine coronary artery model.

Authors:  Gaku Nakazawa; Toshiro Shinke; Takeshi Ijichi; Daisuke Matsumoto; Hiromasa Otake; Sho Torii; Noritoshi Hiranuma; Tsuyoshi Ohsue; Fumiyuki Otsuka; Junya Shite; Ken-Ichi Hirata; Yuji Ikari
Journal:  EuroIntervention       Date:  2014-10       Impact factor: 6.534

7.  Clinical presentation and management of stable coronary artery disease: insights from the international prospective CLARIFY registry - results from the Greek national cohort.

Authors:  Eftihia Sbarouni; Vassilis Voudris; Panagiota Georgiadou; Michalis Hamilos; P Gabriel Steg; Kim M Fox; Nicola Greenlaw; Roberto Ferrari; Panos E Vardas
Journal:  Hellenic J Cardiol       Date:  2014 Nov-Dec

8.  Curcumin delays endometriosis development by inhibiting MMP-2 activity.

Authors:  Sayantan Jana; Deep Sankar Rudra; Sumit Paul; Swarnakar Snehasikta
Journal:  Indian J Biochem Biophys       Date:  2012-10       Impact factor: 1.918

9.  Effects of rosiglitazone treatment on insulin resistance and TNF-alpha levels in patients with chronic kidney disease: a prospective study.

Authors:  T Basturk; A Unsal; T Ulas; Y Koc; T Sakaci; E Ahbap; F Borlu
Journal:  Eur Rev Med Pharmacol Sci       Date:  2012-10       Impact factor: 3.507

10.  Novel Curcumin Diclofenac Conjugate Enhanced Curcumin Bioavailability and Efficacy in Streptococcal Cell Wall-induced Arthritis.

Authors:  S K Jain; M S Gill; H S Pawar; Sarasija Suresh
Journal:  Indian J Pharm Sci       Date:  2014-09       Impact factor: 0.975

View more
  7 in total

1.  miR-590-3p mediates the protective effect of curcumin on injured endothelial cells induced by angiotensin II.

Authors:  Tian Wu; Yuanyuan Xiang; Yu Lv; Dai Li; Lijin Yu; Ren Guo
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  The Therapeutic Role of Slit2 in Anti-fibrosis, Anti-inflammation and Anti-oxidative Stress in Rats with Coronary Heart Disease.

Authors:  Ji-Wei Liu; Hai-Tao Liu; Lin Chen
Journal:  Cardiovasc Toxicol       Date:  2021-08-19       Impact factor: 3.231

3.  Body Fat Changes and Liver Safety in Obese and Overweight Women Supplemented with Conjugated Linoleic Acid: A 12-Week Randomised, Double-Blind, Placebo-Controlled Trial.

Authors:  Edyta Mądry; Ida Judyta Malesza; Mehala Subramaniapillai; Agata Czochralska-Duszyńska; Marek Walkowiak; Anna Miśkiewicz-Chotnicka; Jarosław Walkowiak; Aleksandra Lisowska
Journal:  Nutrients       Date:  2020-06-17       Impact factor: 5.717

Review 4.  Therapeutic Applications of Curcumin Nanomedicine Formulations in Cardiovascular Diseases.

Authors:  Bahare Salehi; María L Del Prado-Audelo; Hernán Cortés; Gerardo Leyva-Gómez; Zorica Stojanović-Radić; Yengkhom Disco Singh; Jayanta Kumar Patra; Gitishree Das; Natália Martins; Miquel Martorell; Marzieh Sharifi-Rad; William C Cho; Javad Sharifi-Rad
Journal:  J Clin Med       Date:  2020-03-10       Impact factor: 4.241

5.  Interactions of selected cardiovascular active natural compounds with CXCR4 and CXCR7 receptors: a molecular docking, molecular dynamics, and pharmacokinetic/toxicity prediction study.

Authors:  Hussam Aly Sayed Murad; Thamer Mohammed Ahmed Alqurashi; Mostafa Aly Hussien
Journal:  BMC Complement Med Ther       Date:  2022-02-04

Review 6.  Protective Effects of Curcumin in Cardiovascular Diseases-Impact on Oxidative Stress and Mitochondria.

Authors:  Fiona Frederike Cox; Angelina Misiou; Annika Vierkant; Niloofar Ale-Agha; Maria Grandoch; Judith Haendeler; Joachim Altschmied
Journal:  Cells       Date:  2022-01-20       Impact factor: 6.600

7.  Therapeutic mechanism of Curcuma aromatica Salisb. rhizome against coronary heart disease based on integrated network pharmacology, pharmacological evaluation and lipidomics.

Authors:  Chenghao Fei; Huangjin Tong; Yu Li; Lianlin Su; Yuwen Qin; Zhenhua Bian; Wei Zhang; Chunqin Mao; Lin Li; Tulin Lu
Journal:  Front Pharmacol       Date:  2022-08-09       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.